RA PHARMACEUTICALS, INC. Capital Expenditures
RA PHARMACEUTICALS, INC. reported Capital Expenditures of $865.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-12-31 was $236.00K, a 98.32% increase year-over-year.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-09-30 was $213.00K, a 40.34% decline year-over-year.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-06-30 was $221.00K, a 58.22% decline year-over-year.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2019-03-31 was $195.00K, a 572.41% increase year-over-year.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2019 was $865.00K, a 16.34% decline from fiscal 2018.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2018 was $1.03M, a 26.77% decline from fiscal 2017.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2017 was $1.41M, a 72.34% decline from fiscal 2016.
- RA PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2016 was $5.11M, a 1442.30% increase from fiscal 2015.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2019-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $449.00K derived: sum of 2 quarters · filed 2020-02-27 | $670.00K derived: sum of 3 quarters · filed 2020-02-27 | $865.00K 10-K · filed 2020-02-27 |
| 2019-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $434.00K derived: sum of 2 quarters · filed 2019-11-07 | $629.00K 10-Q · filed 2019-11-07 | $748.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | $221.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $416.00K 10-Q · filed 2019-08-07 | $535.00K derived: sum of 3 quarters · filed 2020-02-27 | $892.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $195.00K 10-Q · filed 2019-05-09 | $314.00K derived: sum of 2 quarters · filed 2020-02-27 | $671.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.20M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $476.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.00M derived: sum of 3 quarters · filed 2020-02-27 | $1.03M 10-K · filed 2020-02-27 |
| 2018-09-30 | $357.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $886.00K derived: sum of 2 quarters · filed 2019-11-07 | $915.00K 10-Q · filed 2019-11-07 | $937.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $529.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $558.00K 10-Q · filed 2019-08-07 | $580.00K derived: sum of 3 quarters · filed 2019-08-07 | $842.00K derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $29.00K 10-Q · filed 2019-05-09 | $51.00K derived: sum of 2 quarters · filed 2019-05-09 | $313.00K derived: sum of 3 quarters · filed 2019-05-09 | $962.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $284.00K derived: sum of 2 quarters · filed 2019-03-07 | $933.00K derived: sum of 3 quarters · filed 2019-03-07 | $1.41M 10-K · filed 2019-03-07 |
| 2017-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $911.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.39M 10-Q · filed 2018-11-07 | $2.00M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | $649.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $1.13M 10-Q · filed 2018-08-08 | $1.74M derived: sum of 3 quarters · filed 2018-08-08 | $3.01M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $479.00K 10-Q · filed 2018-05-09 | $1.09M derived: sum of 2 quarters · filed 2018-05-09 | $2.36M derived: sum of 3 quarters · filed 2018-05-09 | $5.53M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $611.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $1.88M derived: sum of 2 quarters · filed 2018-03-14 | $5.05M derived: sum of 3 quarters · filed 2018-03-14 | $5.11M 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.44M derived: sum of 2 quarters · filed 2017-11-09 | $4.49M 10-Q · filed 2017-11-09 | $4.67M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $3.22M 10-Q · filed 2017-08-09 | $3.40M derived: sum of 3 quarters · filed 2018-03-14 | |
| 2016-03-31 | $57.00K 10-Q · filed 2017-05-11 | $236.00K derived: sum of 2 quarters · filed 2018-03-14 | ||
| 2015-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $331.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $152.00K 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | $834.00K 10-K · filed 2017-03-06 |